Home
Decoding immunity
We are building an AI model of the immune system to facilitate the development of next-generation immunomodulatory therapeutics.
![](https://www.immunai.com/wp-content/uploads/2022/09/immunai_30_second-720p.jpg)
Platform
Our therapeutics engine is powered by AMICA™, our Annotated Multiomic Immune Cell Atlas , which combines multi-omic single cell analysis with machine learning and functional genomics.
Our Company
Immunai was founded on the belief that immunomics and machine learning could unlock the next generation of immunomodulatory drugs. Learn more about our Founding Story.
We are a multidisciplinary team of immunologists, engineers, drug developers, computer scientists, and entrepreneurs singularly focused on bringing breakthrough medicines to patients. We combine an engineering-first approach and a deep understanding of the immune system to find and validate targets and therapeutics.